Latest Interventional cardiology Stories
Company to Present at European Symposium Titled MGuard(TM) Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 /PRNewswire/ --
Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold.
-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc.
CAESAREA, Israel, May 15, 2014 /PRNewswire/ -- Resources will be channeled towards randomized clinical studies and further commercialization. Keystone Heart
FRAMINGHAM, Mass., May 9, 2014 /PRNewswire/ -- HeartWare International, Inc.
Market Size - $14.94 bn in 2013, Market Growth - CAGR of 7.7%, Market Trends – Growing demand for minimally invasive medical procedures.
Blockages previously deemed untreatable now cleared through hybrid approach developed by interventional cardiologists. Kansas City, MO (PRWEB) May 06, 2014
PLANO, Texas, May 6, 2014 /PRNewswire/ -- Argon Medical Devices, Inc.
For 16 Consecutive Years Mount Sinai Awarded Highest “Two-Star” Rating by New York State Department of Health for Percutaneous Coronary Interventions (PCI) New
SINGAPORE, May 5, 2014 /PRNewswire/ -- Biosensors International Group, Ltd.
A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...
- A transitional zone between two communities containing the characteristic species of each.
More Images (1 images) »